JT-194

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameJT-194
Drug Alias NameNLRP3 inflammasome activation inhibitors (GenenTech)NLRP3 inflammasome activation inhibitors (Jecure Therapeutics)JT-349JT-194
ClassificationSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJecure Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJecure Therapeutics IncGenentech Inc
Active IndicationsN/A
Inactive IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A